ACHV
Achieve Life Sciences, Inc. - Common Shares (ACHV)
$38
About Achieve Life Sciences, Inc. - Common Shares (ACHV)
Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.
Details
Daily high
$7.00
Daily low
$6.25
Price at open
$7.00
52 Week High
$8.64
52 Week Low
$2.62
Market cap
718.3M
Dividend yield
-
Volume
1.6M
Avg. volume
1.3M
P/E ratio
-4.51
Achieve Life Sciences, Inc. - Common Shares News
Details
Daily high
$7.00
Daily low
$6.25
Price at open
$7.00
52 Week High
$8.64
52 Week Low
$2.62
Market cap
718.3M
Dividend yield
-
Volume
1.6M
Avg. volume
1.3M
P/E ratio
-4.51